Ben Goldacre on more bad data: this time from drug companies

ByCarl Zimmer
September 30, 2012

This morning I was accused of writing “corporate sponsored blogs whoring themselves out to all and sundry.” Actually, I was arguing that science writers have a duty to call out weak science and press manipulation rather than cave into it. That applies to any kind of research. I happened to be talking about research on genetically modified foods and their health risks. But it applies just as well to pharmaceutical corporations that deep-six drug trials that don’t support their drugs. The most eloquent critic of this bad behavior is Ben Goldacre. You can watch this video of a TED talk he recently gave on the subject, read this essay in the Guardian, or pre-order his new book, Bad Pharma.

If highlighting Goldacre’s vital work means I have to return my gold-plated corporate-whore Corvette, so be it.

[Update: Guardian link fixed, book title fixed]

LIMITED TIME OFFER

Get a FREE tote featuring 1 of 7 ICONIC PLACES OF THE WORLD

Go Further